SO
FBRX

STRS Ohio’s Forte Biosciences FBRX Stock Holding History

STRS Ohio’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.1K Buy
+1,700
New +$40.3K ﹤0.01% 2073
2022
Q2 		– Sell
-1,076
Closed -$39K – 2120
2022
Q1 		$39K Hold
1,076
– – ﹤0.01% 1975
2021
Q4 		$57K Buy
1,076
+972
+935% +$65.4K ﹤0.01% 1984
2021
Q3 		$7K Hold
104
– – ﹤0.01% 2210
2021
Q2 		$87K Buy
+104
New +$93.7K ﹤0.01% 2003
2018
Q1 		– Sell
-7
Closed -$25K – 1887
2017
Q4 		$25K Hold
7
– – ﹤0.01% 1807
2017
Q3 		$31K Hold
7
– – ﹤0.01% 1844
2017
Q2 		$30K Buy
+7
New +$39.4K ﹤0.01% 1855

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

STRS Ohio's FBRX Position: Q2 2026 in Review

STRS Ohio opened a new position in Forte Biosciences (FBRX) in Q2 2026: 1,700 shares worth $36.1K. The stake represents ﹤0.01% of the portfolio and ranks #2073 among its holdings. This is a return to the name: STRS Ohio previously reported a position in FBRX as recently as Q1 2022.

STRS Ohio first reported a position in FBRX in Q2 2017 and has held it in 8 quarters since. The position peaked at $87K in Q2 2021. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • STRS Ohio held 1,700 shares of Forte Biosciences worth $36.1K as of Q2 2026.
  • Forte Biosciences was a new STRS Ohio position in Q2 2026.
  • Forte Biosciences made up ﹤0.01% of STRS Ohio's portfolio in Q2 2026, its #2073 holding.
  • STRS Ohio first reported a position in Forte Biosciences in Q2 2017 and has held it in 8 quarters since.
  • STRS Ohio's Forte Biosciences position peaked at $87K in Q2 2021.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on STRS Ohio's 13F filing for Q2 2026, filed 30 Jul 2026.